INCRUSE 55mcg single-dose inhalation powder GLAXO SMITH KLINE ORIGINAL MEDICINE
Chemical substance: umeclidinium
Active substance
Results for the substance umeclidinium
1 result
About this active substance
Umeclidinium is a medication used for the treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It belongs to the class of long-acting muscarinic antagonists (LAMA) and works by relaxing the smooth muscles in the airways, reducing bronchoconstriction.
Umeclidinium is administered via inhaler, once daily, as directed by a physician. It is used to relieve COPD symptoms such as shortness of breath, coughing, and chest tightness, improving the quality of life for patients.
Common side effects include headache, dry mouth, and throat irritation. In rare cases, allergic reactions, worsening respiratory symptoms, or urinary retention may occur.
Umeclidinium is an effective therapeutic option for long-term management of COPD, helping to reduce exacerbations and maintain lung function.
Umeclidinium is administered via inhaler, once daily, as directed by a physician. It is used to relieve COPD symptoms such as shortness of breath, coughing, and chest tightness, improving the quality of life for patients.
Common side effects include headache, dry mouth, and throat irritation. In rare cases, allergic reactions, worsening respiratory symptoms, or urinary retention may occur.
Umeclidinium is an effective therapeutic option for long-term management of COPD, helping to reduce exacerbations and maintain lung function.